Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 190 of the 194 references it cites were found in a registry or an index; 91 of the 133 sources its claims cite were checked for support.

Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories

Open access
Hassamal, Sameer · 2023 · Frontiers in Psychiatry

Abstract

In a subset of patients, chronic exposure to stress is an etiological risk factor for neuroinflammation and depression. Neuroinflammation affects up to 27% of patients with MDD and is associated with a more severe, chronic, and treatment-resistant trajectory. Inflammation is not unique to depression and has transdiagnostic effects suggesting a shared etiological risk factor underlying psychopathologies and metabolic disorders. Research supports an association but not necessarily a causation with depression. Putative mechanisms link chronic stress to dysregulation of the HPA axis and immune cell glucocorticoid resistance resulting in hyperactivation of the peripheral immune system. The chronic extracellular release of DAMPs and immune cell DAMP-PRR signaling creates a feed forward loop that accelerates peripheral and central inflammation. Higher plasma levels of inflammatory cytokines, most consistently interleukin IL-1β, IL-6, and TNF-α, are correlated with greater depressive symptomatology. Cytokines sensitize the HPA axis, disrupt the negative feedback loop, and further propagate inflammatory reactions. Peripheral inflammation exacerbates central inflammation (neuroinflammation) through several mechanisms including disruption of the blood-brain barrier, immune cellular trafficking, and activation of glial cells. Activated glial cells release cytokines, chemokines, and reactive oxygen and nitrogen species into the extra-synaptic space dysregulating neurotransmitter systems, imbalancing the excitatory to inhibitory ratio, and disrupting neural circuitry plasticity and adaptation. In particular, microglial activation and toxicity plays a central role in the pathophysiology of neuroinflammation. Magnetic resonance imaging (MRI) studies most consistently show reduced hippocampal volumes. Neural circuitry dysfunction such as hypoactivation between the ventral striatum and the ventromedial prefrontal cortex underlies the melancholic phenotype of depression. Chronic administration of monoamine-based antidepressants counters the inflammatory response, but with a delayed therapeutic onset. Therapeutics targeting cell mediated immunity, generalized and specific inflammatory signaling pathways, and nitro-oxidative stress have enormous potential to advance the treatment landscape. Future clinical trials will need to include immune system perturbations as biomarker outcome measures to facilitate novel antidepressant development. In this overview, we explore the inflammatory correlates of depression and elucidate pathomechanisms to facilitate the development of novel biomarkers and therapeutics.

Overview

CoChat Summary

TL;DR

This narrative review links chronic stress to HPA-axis dysregulation, immune-cell glucocorticoid resistance, DAMP-PRR signaling, peripheral and central inflammation, and depression. It argues that neuroinflammation defines a severe, treatment-resistant depressive subtype and reviews emerging anti-inflammatory and targeted immunomodulatory treatments.

Key findings

  • Neuroinflammation affects up to 27% of patients with MDD and is associated with a more severe, chronic, treatment-resistant trajectory; peripheral CRP >3 mg/L is commonly used to subtype inflammation and correlates with CSF CRP.
  • Chronic stress is proposed to drive HPA-axis dysregulation and glucocorticoid resistance, with elevated IL-1β, IL-6, and TNF-α; in preclinical work, peripheral IL-6 was 27 times higher in susceptible versus resilient mice after repeated social defeat stress, and anti-IL-6 before stress prevented social avoidance.
  • Central effects include BBB disruption, glial activation, and neurotransmitter/network dysfunction; a meta-analysis estimated an 18% increase in TSPO availability in depressed patients, minocycline improved depression with effect sizes as high as 0.71, and MRI most consistently shows reduced hippocampal volumes.
  • Anti-inflammatory augmentation may help: adjunctive anti-inflammatory treatment was reported as 52% more effective than placebo, celecoxib plus sertraline made response 7 times more likely, anti-cytokine treatment had a moderate effect size (Cohen’s d = 0.40), and infliximab reduced HAM-D at week 12 in patients with baseline CRP >5 mg/L.

Methods

  • Narrative overview of pathophysiological mechanisms and emerging anti-inflammatories; no primary data collection or systematic review protocol is described.
  • Synthesizes preclinical animal models, clinical observational studies, postmortem and neuroimaging findings, randomized trials, and meta-analyses.
  • Main analysis is qualitative synthesis, with tables summarizing inflammatory mediators, proposed roles, and emerging therapeutic targets.

Limitations

  • The paper states that evidence linking chronic stress, inflammation, and depression is largely observational and supports association but not necessarily causation.
  • It states that anti-inflammatory data interpretation is limited by small numbers of studies, moderate to large heterogeneity, variations in diagnostic and treatment planning, and inclusion of patients without evidence of inflammation; targeted therapies are mostly limited to animal models or patients with autoimmune/rheumatological conditions.
  • Evident from the text: as a narrative review, it does not describe a systematic search strategy, formal risk-of-bias assessment, or quantitative pooling of the reviewed literature.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fpsyt.2023.1130989

Cites

190 of 190 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 The vicious reciprocal relationship between chronic stress, inflammation, and depression.
Figure 1 The vicious reciprocal relationship between chronic stress, inflammation, and depression.CC BY · PubMed Central
Figure 2 HPA-axis and inflammation. Created with BioRender.com.
Figure 2 HPA-axis and inflammation. Created with BioRender.com.CC BY · PubMed Central
Figure 3 DAMP-PRR signaling. Created with BioRender.com.
Figure 3 DAMP-PRR signaling. Created with BioRender.com.CC BY · PubMed Central
Figure 4 Neuroinflammation and depression. Created with BioRender.com.
Figure 4 Neuroinflammation and depression. Created with BioRender.com.CC BY · PubMed Central

Verification

Claims the paper makes

87 Valid · 8 Not valid · 42 Not checked · 27 Own results and interpretations

99 more claims · 56 with their cited sources checked

Create a free account to see all 164 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 50
  • Probably not a substantial claim. 11
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 194 references

Cited by

See all 578

Metadata

Authors
Hassamal, S.
Affiliations
California University of Science and Medicine (US)
Corresponding author
Hassamal, Sameer
Venue
Frontiers in Psychiatry
Published
2023-05-11
Volume
14
Pages
1130989-1130989
ISSN
1664-0640 (ISSN-L)
OpenAlex
W4376279472
Cited by
578
References
194
Citations by year
2026: 223 · 2025: 239 · 2024: 103 · 2023: 13
FWCI
11.19
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
chronic stress, neuroinflammation, depression, major depressive disorder, HPA axis dysregulation, glucocorticoid resistance, peripheral inflammation, cytokines, blood-brain barrier, microglial activation, glial cells, hippocampal volume, ventral striatum, ventromedial prefrontal cortex, nitro-oxidative stress, inflammatory markers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories. https://app.cochat.ai/papers/10.3389/fpsyt.2023.1130989
The paper
Hassamal, S. (2023). Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2023.1130989

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.